Alamar Biosciences, a protein detection and analysis life sciences company, raised $191.3 in an upsized IPO at $17 per share — the top of its targeted range.
By the numbers: The offering of 11.25 million shares values Alamar at about $1.1 billion, based on outstanding shares.
